WASHINGTON, March 24 /PRNewswire-USNewswire/ -- The following are remarks by Kent Hill, USAID Assistant Administrator for Global Health, on the observance of World Tuberculosis Day 2008:
Although a cure for Tuberculosis (TB) has existed for more than half a century, TB remains one of three leading causes of death worldwide due to infectious disease. TB kills approximately 1.6 million people each year, while HIV/AIDS claims more than two million lives each year, and malaria kills more than one million people each year.
The U.S. Agency for International Development (USAID) has a clear and proven strategy to detect and treat people who suffer from TB. We are helping to make progress in prevention and control, and in 2005, the rate of new TB cases worldwide leveled off for the first time since the World Health Organization (WHO) began collecting data about the disease. Globally, the target of successfully treating 85 percent of TB cases has been met, and we continue to make steady progress toward the target of detecting 70 percent of all cases.
USAID is the lead U.S. government agency in international TB control programs, supporting efforts in 37 countries. USAID works in close partnership with the President's Emergency Plan for HIV/AIDS Relief, which is making significant investments in TB and HIV co-infection, with the Centers for Disease Control and Prevention, and with the National Institutes for Health.
The core of USAID's work in TB is focused on building the capacity of
developing countries to implement effective programs to combat and control
TB. Our programs support the implementation of the WHO Global Plan to Stop
TB, which works to expand and strengthen basic TB programs as the key
intervention for preventing and controlling drug-resistant TB. USAID is a
founding member of the Stop TB partnership, which is comprised of a network
of more than 500 international organizations, countries, donors from the
public and priva
'/>"/>
| SOURCE U.S. Agency for International Development Copyright©2008 PR Newswire. All rights reserved |